We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Review · September 27, 2020

Dipeptidyl Peptidase 4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus

Nature reviews. Endocrinology

 

Additional Info

Nature reviews. Endocrinology
Dipeptidyl Peptidase 4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Nat Rev Endocrinol 2020 Sep 14;[EPub Ahead of Print], CF Deacon

Further Reading